JPWO2021157685A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021157685A5
JPWO2021157685A5 JP2021575877A JP2021575877A JPWO2021157685A5 JP WO2021157685 A5 JPWO2021157685 A5 JP WO2021157685A5 JP 2021575877 A JP2021575877 A JP 2021575877A JP 2021575877 A JP2021575877 A JP 2021575877A JP WO2021157685 A5 JPWO2021157685 A5 JP WO2021157685A5
Authority
JP
Japan
Prior art keywords
hla
derived
cells
class
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021575877A
Other languages
English (en)
Japanese (ja)
Other versions
JP7743980B2 (ja
JPWO2021157685A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/004232 external-priority patent/WO2021157685A1/ja
Publication of JPWO2021157685A1 publication Critical patent/JPWO2021157685A1/ja
Publication of JPWO2021157685A5 publication Critical patent/JPWO2021157685A5/ja
Application granted granted Critical
Publication of JP7743980B2 publication Critical patent/JP7743980B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021575877A 2020-02-07 2021-02-05 ヒトT細胞由来iPS細胞由来の細胞傷害性T細胞 Active JP7743980B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020019548 2020-02-07
JP2020019548 2020-02-07
PCT/JP2021/004232 WO2021157685A1 (ja) 2020-02-07 2021-02-05 ヒトT細胞由来iPS細胞由来の細胞傷害性T細胞

Publications (3)

Publication Number Publication Date
JPWO2021157685A1 JPWO2021157685A1 (https=) 2021-08-12
JPWO2021157685A5 true JPWO2021157685A5 (https=) 2022-11-14
JP7743980B2 JP7743980B2 (ja) 2025-09-25

Family

ID=77199357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021575877A Active JP7743980B2 (ja) 2020-02-07 2021-02-05 ヒトT細胞由来iPS細胞由来の細胞傷害性T細胞

Country Status (6)

Country Link
US (1) US20230071538A1 (https=)
EP (1) EP4101924A4 (https=)
JP (1) JP7743980B2 (https=)
CN (1) CN115087732B (https=)
CA (1) CA3170361A1 (https=)
WO (1) WO2021157685A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023037544A1 (ja) * 2021-09-13 2023-03-16 公益財団法人京都大学iPS細胞研究財団 多能性幹細胞の製造方法
WO2025111589A1 (en) * 2023-11-22 2025-05-30 Medici Therapeutics, Inc. Compositions and methods for enhancing drug resistance in cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070036773A1 (en) * 2005-08-09 2007-02-15 City Of Hope Generation and application of universal T cells for B-ALL
JPWO2011096482A1 (ja) * 2010-02-03 2013-06-13 国立大学法人 東京大学 多能性幹細胞を用いた免疫機能再建法
FI2838548T3 (fi) * 2012-04-17 2023-10-02 Univ Washington Through Its Center For Commercialization HLA:n luokan II puutteelliset solut, HLA:n luokan II puutteelliset solut, jotka kykenevät ilmentämään HLA:n luokan II proteiineja, ja niiden käytöt
JP6164746B2 (ja) 2012-05-22 2017-07-19 国立大学法人 東京大学 抗原特異的t細胞の製造方法
US20170128556A1 (en) * 2013-12-26 2017-05-11 Thyas Co. Ltd. Immunotherapy using t precursor cells derived from pluripotent stem cells having rearranged t cell receptor genes
JP6715482B2 (ja) * 2014-07-18 2020-07-01 国立大学法人京都大学 多能性幹細胞から免疫細胞療法用t細胞を誘導する方法
WO2019070021A1 (ja) * 2017-10-06 2019-04-11 サイアス株式会社 iPS細胞由来の遺伝的多様性を有するT細胞集団の製造方法
WO2019160077A1 (ja) * 2018-02-16 2019-08-22 国立大学法人京都大学 低抗原性細胞の製造方法
CA3177757A1 (en) * 2018-02-16 2019-08-22 Kite Pharma, Inc. Modified pluripotent stem cells and methods of making and use
CA3162755A1 (en) * 2019-11-25 2021-06-03 Kyoto University T-cell master cell bank
CN119730875A (zh) * 2022-06-23 2025-03-28 艾威赛尔生物技术有限公司 包含可切换嵌合抗原细胞表面受体的工程化人t细胞及其制备方法
CN116515740A (zh) * 2023-03-28 2023-08-01 南京艾尔普再生医学科技有限公司 一种低免疫原性iPSC细胞株

Similar Documents

Publication Publication Date Title
JPWO2021157685A5 (https=)
JP1738226S (ja) 人工まつ毛エクステンション分離器
JP2011525191A5 (https=)
JP2018524987A5 (https=)
JP2016040284A5 (https=)
JP2013523783A5 (https=)
MX2016010954A (es) Construcciones de proteina superficial ubicua a2 y usos de las mismas.
WO2017151801A8 (en) Compositions comprising hiv envelopes to induce ch235 lineage antibodies
JP2020518083A5 (https=)
JP2012021028A5 (https=)
KR20180084469A (ko) 음성 데이터 제공 방법 및 장치
NZ594198A (en) Neil3 peptides and vaccines including the same
CN109890843A (zh) 一种abcg2单克隆抗体及其用途
EP4234686A3 (en) Transduction and expansion of cells
RU2015146752A (ru) Новые вакцинные композиции, содержащие иммуностимулирующие олигонуклеотиды
JP2016074548A5 (https=)
JP2005524719A5 (https=)
JP2018538280A5 (https=)
MX2021000102A (es) Materiales y metodos para expresion sin celulas de concatemeros de epitopos de vacuna.
AR115002A1 (es) Ehv con ul18 y/o ul8 inactivados
TWD229645S (zh) 燙睫毛棒
JP2016183083A5 (https=)
DE602006020679D1 (de) Zusammensetzung zur immunisierung gegen mykobakterien
CN112105724A (zh) 无内源hla基因背景的抗原递呈细胞系的构建方法、抗原递呈细胞系及其用途
JP2019500021A5 (https=)